| Reactive oxygen species: a key constituent in cancer survival S Kumari, AK Badana, RR Malla Biomarker insights 13, 1177271918755391, 2018 | 837 | 2018 |
| Tumor microenvironment: Challenges and opportunities in targeting metastasis of triple negative breast cancer KGK Deepak, R Vempati, GP Nagaraju, VR Dasari, S Nagini, DN Rao, ... Pharmacological research 153, 104683, 2020 | 462 | 2020 |
| Localization of uPAR and MMP-9 in lipid rafts is critical for migration, invasion and angiogenesis in human breast cancer cells H Raghu, PK Sodadasu, RR Malla, CS Gondi, N Estes, JS Rao BMC cancer 10, 1-17, 2010 | 154 | 2010 |
| Downregulation of uPAR and cathepsin B induces apoptosis via regulation of Bcl-2 and Bax and inhibition of the PI3K/Akt pathway in gliomas R Malla, S Gopinath, K Alapati, CS Gondi, M Gujrati, DH Dinh, ... PloS one 5 (10), e13731, 2010 | 127 | 2010 |
| Exosomal tetraspanins as regulators of cancer progression and metastasis and novel diagnostic markers RR Malla, S Pandrangi, S Kumari, MM Gavara, AK Badana Asia‐Pacific Journal of Clinical Oncology 14 (6), 383-391, 2018 | 115 | 2018 |
| Multi-targeting andrographolide and its natural analogs as potential therapeutic agents V Kishore, N Sastry Yarla, A Bishayee, S Putta, R Malla, ... Current topics in medicinal chemistry 17 (8), 845-857, 2017 | 69 | 2017 |
| Protective effect of 3-O-methyl quercetin and kaempferol from Semecarpus anacardium against H2O2 induced cytotoxicity in lung and liver cells ADN Kumar, GB Bevara, LK Kaja, AK Badana, RR Malla BMC complementary and alternative medicine 16, 1-13, 2016 | 67 | 2016 |
| Cathepsin B and uPAR knockdown inhibits tumor-induced angiogenesis by modulating VEGF expression in glioma RR Malla, S Gopinath, CS Gondi, K Alapati, DH Dinh, M Gujrati, JS Rao Cancer gene therapy 18 (6), 419-434, 2011 | 67 | 2011 |
| Anthocyanins: Multi-target agents for prevention and therapy of chronic diseases S Putta, NS Yarla, I Peluso, DK Tiwari, GV Reddy, PV Giri, N Kumar, ... Current pharmaceutical design 23 (41), 6321-6346, 2017 | 66 | 2017 |
| Cathepsin B and uPAR regulate self-renewal of glioma-initiating cells through GLI-regulated Sox2 and Bmi1 expression S Gopinath, RR Malla, K Alapati, B Gorantla, M Gujrati, DH Dinh, JS Rao Carcinogenesis 34 (3), 550-559, 2013 | 66 | 2013 |
| Lipid raft integrity is required for survival of triple negative breast cancer cells A Badana, M Chintala, G Varikuti, N Pudi, S Kumari, VR Kappala, ... Journal of breast cancer 19 (4), 372-384, 2016 | 65 | 2016 |
| Reactive oxygen species (ROS): Critical roles in breast tumor microenvironment RR Malla, N Surepalli, B Farran, SV Malhotra, GP Nagaraju Critical Reviews in Oncology/Hematology 160, 103285, 2021 | 63 | 2021 |
| New insight on the role of plasminogen receptor in cancer progression S Kumari, R Malla Cancer growth and metastasis 8, CGM. S27335, 2015 | 59 | 2015 |
| CD151—A Striking Marker for Cancer Therapy VRDRRM Seema Kumari1, Gayatri Devi V.1, Anil Badana1 Biomarkers in Cancer 7, 7-11, 2015 | 59* | 2015 |
| HOTAIR: a potential metastatic, drug-resistant and prognostic regulator of breast cancer GSR Raju, E Pavitra, SS Bandaru, GL Varaprasad, GP Nagaraju, ... Molecular cancer 22 (1), 65, 2023 | 53 | 2023 |
| Lipid rafts disruption induces apoptosis by attenuating expression of LRP6 and survivin in triple negative breast cancer AK Badana, M Chintala, MM Gavara, S Naik, S Kumari, VR Kappala, ... Biomedicine & Pharmacotherapy 97, 359-368, 2018 | 53 | 2018 |
| A perspective on the diagnostics, prognostics, and therapeutics of microRNAs of triple-negative breast cancer RR Malla, S Kumari, MM Gavara, AK Badana, S Gugalavath, DKG Kumar, ... Biophysical reviews 11 (2), 227-234, 2019 | 50 | 2019 |
| Synergistic effects of coralyne and paclitaxel on cell migration and proliferation of breast cancer cells lines S Kumari, AK Badana, GM Mohan, GS Naik, RR Malla Biomedicine & pharmacotherapy 91, 436-445, 2017 | 50 | 2017 |
| Horizons of nanotechnology applications in female specific cancers B Rajitha, RR Malla, R Vadde, P Kasa, GLV Prasad, B Farran, S Kumari, ... Seminars in cancer biology 69, 376-390, 2021 | 48 | 2021 |
| Marine natural compound cyclo (L-leucyl-L-prolyl) peptide inhibits migration of triple negative breast cancer cells by disrupting interaction of CD151 and EGFR signaling KGK Deepak, S Kumari, G Shailender, RR Malla Chemico-biological interactions 315, 108872, 2020 | 47 | 2020 |
Dhananjaya Bhadrapura LakkappaSASTRA UniversityVerified email at scbt.sastra.edu
